[1]
A. Moini, Z. Lavasani, L. Kashani, M. F. Mojtahedi, and N. Yamini, “Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial”, IJRM, vol. 17, no. 9, pp. 653–660, Sep. 2019.